Increasing productivity and efficiency during development and production of biotherapeutics and vaccines.
More immunoassay data. Less time.
That’s productivity.
Tiny technology. Big capability.
Easy-to-use kits require fewer manual steps, reducing hands-on time and risk for error.
Designed for 21 CFR Part 11 compliance.
Get in touch
